Screener
Amgen AMGN Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $574M+5.9% | $559M+10.0% | $604M+24.0% | $737M+69.4% | $542M+10.8% | ||
| $10.23B+17.5% | $9.14B+12.4% | $9.57B+41.1% | $8.49B+16.0% | $8.7B+25.5% | ||
| $6.22B-5.5% | $6.19B-8.1% | $6.23B-11.0% | $6.35B-13.8% | $6.58B-17.7% | ||
| $34.96B+30.8% | $31.48B+16.9% | $29.06B+0.1% | $27.89B+4.2% | $26.73B-1.7% | ||
| $8.55B+24.7% | $8.22B+23.0% | $7.91B+20.9% | $7.22B+17.3% | $6.86B+12.4% | ||
| $18.67B0.0% | $18.67B+0.2% | $18.68B+0.2% | $18.68B+0.1% | $18.67B+0.3% | ||
| $19.78B-17.3% | $20.67B-16.2% | $21.57B-22.1% | $22.43B-19.4% | $23.9B-17.6% | ||
| $470M-90.4% | $6.01B+9.6% | $389M-90.7% | $6.82B+34.8% | $4.9B+41.2% | ||
| $95.64B+8.8% | $92.5B+3.5% | $90.59B-1.4% | $90.14B-0.8% | $87.9B-3.3% | ||
| $2.87B-4.8% | $2.94B+22.0% | $2.37B+24.1% | $2.84B+32.2% | $3.01B+32.8% | ||
| $5.45B+123% | $5.44B+61.4% | $4.6B+29.5% | $2.15B-39.2% | $2.44B-55.8% | ||
| $25.5B+24.5% | $24.96B+8.5% | $25.49B+10.3% | $21.79B+7.3% | $20.48B-4.8% | ||
| $51.86B-3.5% | $51.89B-3.9% | $50.01B-11.6% | $52.43B-7.8% | $53.76B-5.9% | ||
| $937M-15.5% | $965M-1.9% | $988M-12.4% | $999M+0.1% | $1.11B-2.2% | ||
| 2.8B0.0% | 2.8B0.0% | 2.8B-91.8% | 2.8B0.0% | 2.8B0.0% | ||
| -$22.28B+13.4% | -$24.65B+9.2% | -$25.11B+9.0% | -$23.8B+6.8% | -$25.71B+5.2% | ||
| $11.69B+57.4% | $9.19B+48.1% | $8.66B+47.3% | $9.62B+27.8% | $7.43B+25.4% | ||
| $95.64B+8.8% | $92.5B+3.5% | $90.59B-1.4% | $90.14B-0.8% | $87.9B-3.3% |
FAQ
- What are Amgen's total assets?
- Amgen (AMGN) holds $95.6B in total assets, up 8.8% year over year.
- How much debt does Amgen have?
- Amgen carries $57.3B in total debt against $11.7B of shareholders' equity, a debt-to-equity ratio of 4.90.
- How much cash does Amgen have?
- Amgen holds $574.0M in cash and equivalents.
- Can Amgen cover its short-term obligations?
- Its current ratio is 1.37 — current assets exceed current liabilities.
- Where does Amgen's balance sheet data come from?
- Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
